Received for publication October 29, 2007.
Revised January 24, 2008.
Accepted for publication January 24, 2008.

Predictions of Hepatic Disposition Properties Using a Mechanistically Realistic, Physiologically Based Model

Abstract

Quantitative mappings were established between drug physicochemical properties (PCPs) and parameter values of a physiologically based, mechanistically realistic, In Silico Liver (ISL). The ISL plugs together autonomous software objects that represent mechanistic hepatic components at different scales and levels of detail. Microarchitectural features are represented separately from the mechanisms that influence drug metabolism. The same ISL has been validated against liver perfusion data for sucrose and four cationic drugs: antipyrine, atenolol, labetalol, and diltiazem. Those parameters sensitive to drug-specific PCPs were tuned so that ISL outflow profiles from a single ISL matched in situ, perfused rat liver, outflow profiles of all five compounds. Quantitative relationships were then established between the four sets of drug PCPs and the corresponding four sets of PCP-sensitive, ISL parameter values; those relationships were used to predict PCP-sensitive, ISL parameter values for prazosin and propranolol given only their PCPs. Relationships were established using three different methods: 1) a simple linear correlation method, 2) the Fuzzy c-Means algorithm, and 3) a simple artificial neural network. Each relationship was used separately to predict PCP-sensitive, ISL parameter values for prazosin and propranolol given their PCPs. Those PCP-sensitive, ISL parameter values were applied in the ISL used earlier to predict the hepatic disposition details for each drug. Although we had available only sparse data, all predicted disposition profiles were judged reasonable (within a factor of two of referent profile data). The order of precision, based on a Similarity Measure, was 3 > 2 > 1.

Key words: computational models, computer modeling and simulation, drug disposition, hepatic elimination, hepatic transport, hepatic uptake, pharmacokinetic modeling, physiologically-based modeling

This article has been cited by other articles:

				T. N. Lam and C. A. Hunt Discovering Plausible Mechanistic Details of Hepatic Drug Interactions Drug Metab. Dispos., January 1, 2009; 37(1): 237 - 246. [Abstract] [Full Text] [PDF]

				S. Park, G. E. P. Ropella, S. H. J. Kim, M. S. Roberts, and C. A. Hunt Computational Strategies Unravel and Trace How Liver Disease Changes Hepatic Drug Disposition J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 294 - 305. [Abstract] [Full Text] [PDF]